DENVER--(BUSINESS WIRE)--The Sorin Group (MIL:SRN), the largest European cardiovascular company and world leader in medical technologies for cardiac surgery, announced today the first commercial implant of the Mitroflow Aortic Pericardial Heart ValveTM in the United States, performed by the Cardiovascular Surgery Division at Mayo Clinic in Rochester, Minnesota.
